Merck Seeks Authorization From US Regulators for Antiviral COVID-19 Treatment

Contact Your Elected Officials
The Epoch Times Header

Merck and its partner on Monday announced they filed an emergency use authorization application with the U.S. Food and Drug Administration (FDA) for their oral antiviral medicine for the treatment of COVID-19.

The pill is meant to combat cases of mild or moderate COVID-19.

Merck said last week that an interim analysis of its phase 3 trial studying the drug showed it was effective in cutting the risk of hospitalization, a key measure in COVID-19 treatments.

The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a summary Merck released.

The results were touted by the companies and a number of experts, including former FDA Commissioner Scott Gottlieb.

“This is a phenomenal result. I mean, this is a profound game changer, to have an oral pill that had this kind of effect, this magnitude of effect in patients who are at high risk who are already symptomatic,” Gottlieb said on CNBC’s “Squawk Box.”

But full results have not yet been published and other experts have said they’re worried about how the pill attacks the virus.

Molnupiravir embeds itself in the virus’s genetic material and causes a high number of mutations, ultimately overwhelming it to extinction, a process known as lethal mutagenesis.

Researchers have said that the method carries risk potential because “the same mutagenic activity that impacts viral replication has the potential for incorporation and mutagenesis of host DNA,” which could contribute to the development of cancer or cause birth defects in an unborn baby. That’s what happened during testing of NHC, the compound molnupiravir creates.

“There is a concern that this will cause long-term mutation effects, even cancer,” Dr. Shuntai Zhou, a scientist at the Swanstrom Lab at the University of North Carolina, told Barron’s.

By Zachary Stieber

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Chambers of Horror

Using a shutdown to legislate is like using a flame thrower to light a candle, it provides light momentarily but destroys everything in its path.

Government Shutdown, Health Care, Tax Breaks=Perfect Storm

The shutdown over cuts to health subsidies for the poor stems from Trump’s OBBB plan, which critics say funneled trillions to the wealthy.

3I/Atlas Comet or UFO Arrives Tomorrow!

The 3I/Atlas object is hurtling toward our solar system on a strange path and composition, set to pass behind the sun, obscuring visual and radio tracking.

‘I’d Be Finished’: Vaccine Researcher Trashes Own Study to Save Career

Most doctors comply with the system, following orders to keep their jobs, income, and prestige, even if it means setting aside independent judgment.

Kamala, Please Run Again

Kamala Harris hinted she wants to run for President in 2028, despite poor poll numbers and her loss in 2024. If she runs, the big winners will be the GOP.

San Jose Proclaims ‘Republic of China Day,’ Honors Taiwanese Community’s Contributions

San Jose declared Oct. 25 “Republic of China Day,” honoring the Taiwanese American community’s cultural and economic contributions to the city.

US Tightens Ban on Chinese Tech Gears

The United States has extended its ban on Chinese electronics to cover products partly made by companies blacklisted on national security grounds.

FDA Says It’s Eliminating Requirements for Generic Versions of Expensive Drugs

The Food and Drug Administration in draft guidance said it will reduce instances where large human trials are required for biosimilars.

Government Shutdown Could Cost US Economy $14 Billion: CBO

The government shutdown could cost the U.S. economy up to $14 billion, a new analysis by the CBO said on Oct. 29.

Trump, Japanese PM Sign Critical Minerals, Rare Earths Deal

The U.S. president visited Tokyo on the second leg...

Trump Hikes Canada’s Tariffs by 10 Percent for Not Pulling Anti-Tariff Ad Immediately

Trump announced he will increase tariffs on Canada by 10% after ad by provincial government of Ontario misrepresented President Reagan’s speech on tariffs.

Trump Rolls Back Emissions Rules on Copper Smelters

President Trump issued a proclamation aimed at reversing a Biden-era environmental rule that enforced stricter air emission standards on copper smelters.

Donor Gives $130 Million to Cover Shortfall in Troop Pay During Shutdown

Trump announced on Oct. 23 that an anonymous donor sent $130M to cover military pay during the ongoing government shutdown.
spot_img

Related Articles

Popular Categories

MAGA Business Central